Pancreatic Cancer Research

ResearcherVeterans Health AdministrationActive in the last 2 years

Burcu Saka

Matched on ORCID iD 0000-0002-2043-2041; OpenAlex author ID A5101405318. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2013: 2 papers · 2014: 3 papers · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 11

  1. "Simple Mucinous Cysts" associated with pancreatic ductal adenocarcinoma: clinicopathologic and radiologic characterization of an enigmatic cyst and additional… Co-author DOI 10.1007/s00428-026-04705-w↗
  2. "Horses out of the barn": pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accura… Co-author DOI 10.1111/his.70099↗
  3. Delayed gastric emptying associated with Strongyloides stercoralis infection and pancreatic adenocarcinoma. Co-author DOI 10.47717/turkjsurg.2025.2025-4-39↗
  4. Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Editio… Co-author DOI 10.1245/s10434-016-5093-7↗
  5. High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2014.11.004↗
  6. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TN… First author DOI 10.1245/s10434-015-4861-0↗
  7. Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. Co-author DOI 10.1038/onc.2013.488↗
  8. CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-13-1996↗
  9. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. First author DOI 10.1158/1078-0432.ccr-13-1239↗
  10. Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.28144↗
  11. KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas. Co-author DOI 10.1038/modpathol.2013.71↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Volkan N. Adsay · 10 shared papers, 2013–2026 · strength 0.80
  2. Olca Baştürk · 4 shared papers, 2015–2026 · strength 0.57
  3. Michelle Dian Reid · 4 shared papers, 2015–2026 · strength 0.57
  4. Pelin Bağcı · 4 shared papers, 2015–2026 · strength 0.57
  5. Shishir Kumar Maithel · 7 shared papers, 2013–2026 · strength 0.47
  6. Bassel F. El‐Rayes · 7 shared papers, 2013–2026 · strength 0.47
  7. David A. Kooby · 6 shared papers, 2013–2026 · strength 0.42
  8. Alyssa M. Krasinskas · 4 shared papers, 2013–2026 · strength 0.38
  9. Juan Manuel Sarmiento · 3 shared papers, 2015–2026 · strength 0.33
  10. Ozgur Aktas · 1 shared paper, 2026 · strength 0.30
  11. Gürkan Tellioğlu · 1 shared paper, 2026 · strength 0.30
  12. Önder Ergönül · 1 shared paper, 2026 · strength 0.30
  13. Cisel A. Mericoz · 1 shared paper, 2026 · strength 0.24
  14. Nuray Tezcan · 1 shared paper, 2026 · strength 0.24
  15. Jerome Carl Landry · 4 shared papers, 2013–2015 · strength 0.14
  16. Lauren Elizabeth Colbert · 4 shared papers, 2013–2015 · strength 0.14
  17. Walter John Curran · 4 shared papers, 2013–2015 · strength 0.14
  18. William Adrian Hall · 3 shared papers, 2013–2014 · strength 0.09
  19. David S. Yu · 3 shared papers, 2013–2014 · strength 0.09
  20. Lauren McLendon Postlewait · 2 shared papers, 2015–2016 · strength 0.09
  21. Simion I. Chiosea · 1 shared paper, 2013 · strength 0.05
  22. Erica J. Childs · 1 shared paper, 2014 · strength 0.04
  23. Haeryoung Kim · 1 shared paper, 2014 · strength 0.04
  24. Joseph M. Herman · 1 shared paper, 2014 · strength 0.04
  25. Christopher Lee Wolfgang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.